| Application no. and date | 00935031.5 (espacenet) (Federated) (European Patent Register), 20000516 | | Patent/reg. no. and date | DK/EP 1185272, 20040407 | | Publication date | 20020313 | | Priority no. and date | EP 99109295, 19990527 | | EP pub. no. and date |
EP 1185272 20020313 | | Effective date | | | Applicant/owner | MERCK PATENT GmbH, Frankfurter Strasse 250
64293 Darmstadt, DE | | Applicant ref. no. | 37178 DK 01 | | Inventor | BÖTTCHER, Henning, Theodor-Heuss-Strasse 13
D-64287 Darmstadt, DE,
BARTOSZYK, Gerd, Kreuzstrasse 57
D-64331 Weiterstadt, DE,
SEYFRIED, Christoph, Mathildenstrasse 6
D-64342 Seeheim, DE,
SEDMAN, Ewen, The Barley House
Dene Lea
Ropley
Alresford,
Hampshire SO24 0BH, GB,
VAN AMSTERDAM, Christoph, Schepp Allee 47
D-64295 Darmstadt, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/00, A61P 25/18, A61P 25/24, A61K 31/495 | | Title | Hidtil ukendt anvendelse af 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazin og dets fysiologisk acceptable salte til behandling af bipolære lidelser og mani | | Int. application no. | EP2000004376 | | Int. publication no. | WO2000072832 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
